New group therapy aims to quiet voices in schizophrenia
NCT ID NCT07266376
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a 15-session group therapy program for people with schizophrenia who still hear voices despite medication. The program combines several proven strategies to help reduce how often the voices occur and how much distress they cause. Researchers will compare the therapy group to a control group to see if it improves symptoms like anxiety and depression. The goal is to offer a non-drug option for managing treatment-resistant auditory hallucinations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- integrative group therapy (behavioral intervention)
- What this could lead to
- If it works, this program could offer a practical, non-drug way to reduce the frequency and distress of voices for people with schizophrenia who don't respond to medication.
- What could go wrong
- This is a relatively small, early-stage trial with 116 participants. The therapy is time-intensive (15 weekly sessions) and may not work for everyone. Results may not apply to all people with schizophrenia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENTAL DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Public Mental Health Institution of Guadeloupe
Les Abymes, 97139, Guadeloupe
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a diabetes drug curb opioid addiction? a trial puts semaglutide to the test
- Can a tailored self-management program improve health outcomes for those with serious mental illness?
- Could a smartphone app help people on mental health waiting lists feel more prepared?
- Digital dream team: personalized advice may cut Long-Term sick leave
- PET scans reveal how antipsychotics target key brain receptors in schizophrenia
- Could better nutrition care transform recovery for older mental health patients?